Trial Outcomes & Findings for Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence (NCT NCT00300235)
NCT ID: NCT00300235
Last Updated: 2019-02-01
Results Overview
Subject responded YES to survey Question "Have you ever had priapism?". By diagnosis and age group. Enumeration of the prevalence of priapism in males with sickle cell anemia and sickle beta zero thalassemia.
COMPLETED
1464 participants
At time of interview
2019-02-01
Participant Flow
Participant milestones
| Measure |
Age 5-9.9 HbSS/HbSβ0
Subjects 5 to 9.9 yrs w/SCD diagnosis HbSS/HbSβ0
|
Age 10-14.9 HbSS/HbSβ0
Subjects 10 to 14.9 ys w/SCD diagnosis HbSS/HbSβ0
|
Age 15-24.9 HbSS/HbSβ0
Subjects 15 to 24.9 yrs w/SCD diagnosis HbSS/HbSβ0
|
Age >25 HbSS/HbSβ0
Subjects \> 25 yrs w/SCD diagnosis HbSS/HbSβ0
|
Age >15 HbSC/HbSβ+
Subjects \> 15 yrs w/SCD diagnosis HbSC/HbSβ+
|
|---|---|---|---|---|---|
|
Overall Study
STARTED
|
208
|
240
|
398
|
362
|
251
|
|
Overall Study
COMPLETED
|
208
|
240
|
398
|
362
|
251
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
0
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence
Baseline characteristics by cohort
| Measure |
Age 5-9.9 HbSS/HbSβ0
n=208 Participants
Subjects 5 to 9.9 yrs w/SCD diagnosis HbSS/HbSβ0
|
Age 10-14.9 HbSS/HbSβ0
n=240 Participants
Subjects 10 to 14.9 ys w/SCD diagnosis HbSS/HbSβ0
|
Age 15-24.9 HbSS/HbSβ0
n=398 Participants
Subjects 15 to 24.9 yrs w/SCD diagnosis HbSS/HbSβ0
|
Age >25 HbSS/HbSβ0
n=362 Participants
Subjects \> 25 yrs w/SCD diagnosis HbSS/HbSβ0
|
Age >15 HbSC/HbSβ+
n=251 Participants
Subjects \> 15 yrs w/SCD diagnosis HbSC/HbSβ+
|
Total
n=1459 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|---|
|
Age, Categorical
<=18 years
|
208 Participants
n=5 Participants
|
240 Participants
n=7 Participants
|
203 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
84 Participants
n=21 Participants
|
735 Participants
n=10 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
195 Participants
n=5 Participants
|
361 Participants
n=4 Participants
|
165 Participants
n=21 Participants
|
721 Participants
n=10 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
1 Participants
n=4 Participants
|
2 Participants
n=21 Participants
|
3 Participants
n=10 Participants
|
|
Age, Continuous
|
7.4 years
STANDARD_DEVIATION 1.44 • n=5 Participants
|
12.6 years
STANDARD_DEVIATION 1.46 • n=7 Participants
|
19.3 years
STANDARD_DEVIATION 2.72 • n=5 Participants
|
36.0 years
STANDARD_DEVIATION 8.93 • n=4 Participants
|
29.8 years
STANDARD_DEVIATION 13.69 • n=21 Participants
|
22.5 years
STANDARD_DEVIATION 12.65 • n=10 Participants
|
|
Sex: Female, Male
Female
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=10 Participants
|
|
Sex: Female, Male
Male
|
208 Participants
n=5 Participants
|
240 Participants
n=7 Participants
|
398 Participants
n=5 Participants
|
362 Participants
n=4 Participants
|
251 Participants
n=21 Participants
|
1459 Participants
n=10 Participants
|
|
Region of Enrollment
United States
|
208 participants
n=5 Participants
|
240 participants
n=7 Participants
|
398 participants
n=5 Participants
|
362 participants
n=4 Participants
|
251 participants
n=21 Participants
|
1459.0 participants
n=10 Participants
|
PRIMARY outcome
Timeframe: At time of interviewPopulation: All particpants who completed survey were analyzed.
Subject responded YES to survey Question "Have you ever had priapism?". By diagnosis and age group. Enumeration of the prevalence of priapism in males with sickle cell anemia and sickle beta zero thalassemia.
Outcome measures
| Measure |
Age 5-9.9 HbSS/HbSβ0
n=208 Participants
Subjects 5 to 9.9 yrs w/SCD diagnosis HbSS/HbSβ0
|
Age 10-14.9 HbSS/HbSβ0
n=240 Participants
Subjects 10 to 14.9 ys w/SCD diagnosis HbSS/HbSβ0
|
Age 15-24.9 HbSS/HbSβ0
n=398 Participants
Subjects 15 to 24.9 yrs w/SCD diagnosis HbSS/HbSβ0
|
Age >25 HbSS/HbSβ0
n=362 Participants
Subjects \> 25 yrs w/SCD diagnosis HbSS/HbSβ0
|
Age >15 HbSC/HbSβ+
n=251 Participants
Subjects \> 15 yrs w/SCD diagnosis HbSC/HbSβ+
|
|---|---|---|---|---|---|
|
Enumeration of the Prevalence of Priapism in Males With Sickle Cell Anemia and Sickle Beta Zero Thalassemia.
|
18 participants
|
58 participants
|
160 participants
|
189 participants
|
60 participants
|
SECONDARY outcome
Timeframe: Cross-sectional single survey visitCharacterization of priapism in males with sickle cell anemia with reference to time of onset, duration of events, frequency of episodes, precipitating or associated activities, treatment modalities used, and outcome of treatments.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Cross-sectional single survey visitDescriptive comparison of the prevalence of priapism in males with sickle cell anemia to that described in older patients with other sickle hemoglobinopathies.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Cross-sectional single survey visitAssessment of general patient and parent understanding of priapism as a complication of sickle cell disease gained from completion of protocol.
Outcome measures
Outcome data not reported
Adverse Events
Age 5-9.9 HbSS/HbSβ0
Age 10-14.9 HbSS/HbSβ0
Age 15-24.9 HbSS/HbSβ0
Age >25 HbSS/HbSβ0
Age >15 HbSC/HbSβ+
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place